Arena Pharma (ARNA) PT Raised to $115 at Guggenheim Following Deep Dive Into Etrasimod Dermatitis Readout
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja raised the price target on Arena Pharma (NASDAQ: ARNA) to $115.00 (from $95.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE